These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10067261)

  • 21. [Efficacy of lornoxicam and ketorolac in the prevention and treatment of postoperative pain syndrome in neurosurgical patients].
    Petrov VI; Sabanov AV; Medvedev VG; Semenov PA; Tyrsin OIu
    Khirurgiia (Mosk); 2009; (2):64-70. PubMed ID: 19368046
    [No Abstract]   [Full Text] [Related]  

  • 22. Arthritis: anti-inflammatory drugs in practice.
    Dieppe P; Doyle D; Jacoby R
    Practitioner; 1981 Mar; 225(1353):397-9. PubMed ID: 7022432
    [No Abstract]   [Full Text] [Related]  

  • 23. [Selective COX 2 inhibitor rofecoxib. To "defy" the pain].
    MMW Fortschr Med; 2003 Aug; 145(31-32):56-7. PubMed ID: 14524083
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonprescription dental pain relief.
    Dent Today; 2004 Dec; 23(12):48. PubMed ID: 15633820
    [No Abstract]   [Full Text] [Related]  

  • 25. What now about acetaminophen?
    Zwahlen M; Jüni P; Egger M
    Arch Intern Med; 2003 Aug 11-25; 163(15):1862-3; author reply 1863. PubMed ID: 12912727
    [No Abstract]   [Full Text] [Related]  

  • 26. [Overestimated].
    Höer A; Häussler B
    Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness and tolerance of celebrex in osteoarthrosis (data of a Russian study)].
    Tsvetkova ES; Alekseeva LI; Balabanova RM; Chichasova NV; Shostak NA; Shmidt EI
    Ter Arkh; 2001; 73(5):61-3. PubMed ID: 11517754
    [No Abstract]   [Full Text] [Related]  

  • 28. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 30. Tempering the enthusiasm for COX-2 inhibitors.
    Nuovo J
    Am Fam Physician; 2000 Jun; 61(12):3560, 3563. PubMed ID: 10892630
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
    Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
    MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of analgesics on pre- and post-separator pain.
    Patel S
    Todays FDA; 2010; 22(5):46-9, 51, 53. PubMed ID: 21090046
    [No Abstract]   [Full Text] [Related]  

  • 35. Phosphatidylcholine association increases the anti-inflammatory and analgesic activity of ibuprofen in acute and chronic rodent models of joint inflammation: relationship to alterations in bioavailability and cyclooxygenase-inhibitory potency.
    Lichtenberger LM; Romero JJ; de Ruijter WM; Behbod F; Darling R; Ashraf AQ; Sanduja SK
    J Pharmacol Exp Ther; 2001 Jul; 298(1):279-87. PubMed ID: 11408553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Celebrex: confirmed effectiveness and safety (new data)].
    Nasonov EL
    Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug testing. Massive trial of Celebrex seeks to settle safety concerns.
    Couzin J
    Science; 2005 Dec; 310(5756):1890-1. PubMed ID: 16373546
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy: Cardiovascular safety of celecoxib, naproxen and ibuprofen.
    Nurmohamed MT
    Nat Rev Rheumatol; 2017 Mar; 13(3):136-138. PubMed ID: 28127041
    [No Abstract]   [Full Text] [Related]  

  • 39. Ibuprofen or acetaminophen in children? As the debate continues, the evidence may favor ibuprofen.
    Mennick F
    Am J Nurs; 2004 Sep; 104(9):20. PubMed ID: 15365323
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.